Search fresh public links, source activity, and ready-to-use post angles for Retatrutide.
Fresh curated links around Retatrutide are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Ever since Ozempic entered the market in 2018 to treat diabetes, the GLP-1 market has exploded. In less than a decade, new therapies have been introduced, including Wegovy, Tirzepa...
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
Patients are asking about retatrutide as UCHealth coverage brings attention to next-generation peptide therapies and their role in future obesity treatment models. The post Retatru...
Retatrutide is one of those drugs. It helped people lose a massive amount of weight in clinical trials. It also improved sleep apnea and knee pain.
The buzz around weight-loss drugs has never been louder or more exciting, especially when it comes to a brand new option called retatrutide or “reta”—stuff so powerful it’s basical...
The FDA has approved olezarsen as the first and only therapy, alongside diet, to lower triglycerides and acute pancreatitis risk in patients with severe hypertriglyceridemia, accor...
Even as industry watchers pit the two assets against one another, it’s too early to say whose next-generation incretin stands supreme between Novo Nordisk’s CagriSema and Eli Lilly...
In patients with severe hypertriglyceridemia, olezarsen lowered triglycerides and reduced acute pancreatitis events compared with placebo, researchers reported at the European Athe...
Twice a day oral drug is priced at ₹2.15 lakh for two weeks treatment
Myovant Anonymous (not verified) Tue, 06/09/2026 - 17:50 field_thread_url https://cafepharma.com/boards/threads/myovant.655728/ board na...
New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and too fast to lose?
Digestive health is a significant concern, with a steadily growing percentage of the population experiencing issues related to gut function. Reta 10mg (GLP-3), a formulation catego...
The world of weight management is evolving faster than ever, and a new drug discovery is setting a historic milestone for obesity treatment.
As the American Diabetes Association 2026 Scientific Sessions kicked off in New Orleans over the weekend, Zealand Pharma and its recent commercial and development partner Roche hel...
Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugsA new triple-action weekly jab for type 2 diabetes could...
Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic hea...
Myovant Anonymous (not verified) Sat, 06/06/2026 - 17:46 field_thread_url https://cafepharma.com/boards/threads/myovant.655728/ board na...
Learn about retatrutide, a new weight-loss drug that works differently than other GLP-1s and helped patients in a clinical trial lose up to 85 pounds.
Eli Lilly’s retatrutide set a high mark in weight loss for obesity drugs, but with clinical trial results that show some new side effects. More detailed data from the Phase 3 study...
On the heels of a strong showing for the drug earlier this year, Pfizer is padding the case for the GLP-1 receptor agonist it picked up in its $10 billion purchase of obesity biote...
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Searches for what to do when Tirzepatide stops working are climbing as patients who once saw fast weight-loss results begin hitting the stall nobody warned them about. California T...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.